Clinical Trials Browser

Solid Tumors × Clofarabine × Clear all

NCT00125827 2014-03-19

Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors